Comparison of improvements of aqueous dissolution of structurally analogous hydrophobic drugs by amorphous solid dispersion

被引:6
|
作者
Okamoto, Takashi [1 ]
Yamamoto, Kayoko [1 ]
Sekitoh, Takanari [1 ]
Fujioka, Akiho [1 ]
Imanaka, Hiroyuki [1 ]
Ishida, Naoyuki [1 ]
Imamura, Koreyoshi [1 ]
机构
[1] Okayama Univ, Grad Sch Nat Sci & Technol, Div Appl Chem, Kita Ku, 3-1-1 Tsushima Naka, Okayama 7008530, Japan
关键词
Amorphous solid dispersion; Amorphous sugar; Hydrophobic drug; Vacuum foam drying; Ibuprofen; Melting point; HOT-MELT EXTRUSION; SOLUBLE DRUGS; SOLUBILITY; SUPERSATURATION; STRATEGIES; SYSTEMS; BIOAVAILABILITY; INDOMETHACIN; ENHANCEMENT; TEMPERATURE;
D O I
10.1016/j.colsurfa.2021.127744
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Amorphous solid dispersion (ASD) technique is promising to increase the dissolution of hydrophobic drug in aqueous solution systems, including in vivo. However, there is a serious lack of understanding of the impact of the molecular characteristics of a hydrophobic drug on the aqueous dissolution behavior of the drug from the ASD. This is because there are many structural differences between different types of drugs, which crucially complicates our understanding of the impact of each structural difference on the drug dissolution behavior. Hence, in this study, systematically different molecular structures of model drugs (ibuprofen, IBP, and its congeners) were employed to be solid-dispersed and their aqueous dissolution profiles were compared. Amorphous solid dispersions of the model drugs were prepared by a sole-amorphous sugar-based solid dispersion, SAS-SD, in which drug carrier is comprised solely of sugar. Aqueous dissolution profiles of the drugs were characterized using the maximum concentration (C-max) and the time-integrated concentration of the dissolved drug (AUC(60)( min)). Comparisons of the dissolution profiles and thermal characteristics of the IBP congeners revealed that the IBP congener with a lower melting point (T-m) exhibited a greater improvement in the C-max and AUC(60) (min )by the SAS-SD. Heat treatment of SAS-SD samples at 120 degrees C for 60 min were conducted to further improve the drug dissolution. The results indicated an enhanced increase in the dissolution of two IBP congeners whose T-m = 97 degrees C and 117 degrees C but no significant effect for higher T-m congeners. Based on these findings, the issue of how the drug T-m affects the improvement in the drug dissolution by the SAS-SD and heat treatment is discussed.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Surface Characterization as a Tool for Identifying the Factors Affecting the Dissolution Rate of Amorphous Solid Dispersion Tablets
    Yu, Dongyue
    Fiddler, Frederick
    Ibrahim, Ahmed
    Sanedrin, Raymond
    Tremblay, Heidi
    Hoag, Stephen W.
    AAPS PHARMSCITECH, 2022, 23 (08)
  • [42] Mechanistic elucidation of formation of drug-rich amorphous nanodroplets by dissolution of the solid dispersion formulation
    Ueda, Keisuke
    Higashi, Kenjirou
    Moribe, Kunikazu
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 561 : 82 - 92
  • [43] Physicochemical and Pharmacokinetic Characterization of Amorphous Solid Dispersion of Meloxicam with Enhanced Dissolution Property and Storage Stability
    Masanori Ochi
    Keisuke Kimura
    Atsushi Kanda
    Takaki Kawachi
    Akitoshi Matsuda
    Kayo Yuminoki
    Naofumi Hashimoto
    AAPS PharmSciTech, 2016, 17 : 932 - 939
  • [44] Physicochemical and Pharmacokinetic Characterization of Amorphous Solid Dispersion of Meloxicam with Enhanced Dissolution Property and Storage Stability
    Ochi, Masanori
    Kimura, Keisuke
    Kanda, Atsushi
    Kawachi, Takaki
    Matsuda, Akitoshi
    Yuminoki, Kayo
    Hashimoto, Naofumi
    AAPS PHARMSCITECH, 2016, 17 (04): : 932 - 939
  • [45] The interplay of dissolution, solution crystallization and solid-state transformation of amorphous indomethacin in aqueous solution
    Schneider, Raj
    Kerkhoff, Jana
    Danzer, Andreas
    Mattusch, Amelie
    Ohmann, Andrijan
    Thommes, Markus
    Sadowski, Gabriele
    INTERNATIONAL JOURNAL OF PHARMACEUTICS-X, 2020, 2
  • [46] Polymeric solid dispersion Vs co-amorphous technology: A critical comparison
    Vullendula, Sai Krishna Anand
    Nair, Athira R.
    Yarlagadda, Dani Lakshman
    Sree, K. S. Navya
    Bhat, Krishnamurthy
    Dengale, Swapnil J.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 78
  • [47] Mechanism of Dissolution-Induced Nanoparticle Formation from a Copovidone-Based Amorphous Solid Dispersion
    Harmon, Paul
    Galipeau, Kendra
    Xu, Wei
    Brown, Chad
    Wuelfing, W. Peter
    MOLECULAR PHARMACEUTICS, 2016, 13 (05) : 1467 - 1481
  • [48] Formulation and evaluation of amorphous solid dispersion Boerhaavia diffusa methanolic root extract for improving dissolution properties
    Bhalodiya, Monika
    Chavda, Jayant
    Mori, Dhaval
    Patel, Nilesh
    Manek, Ravi
    Dudhat, Kiran
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2021, 66
  • [49] Enhancement of dissolution and bioavailability of ezetimibe by amorphous solid dispersion nanoparticles fabricated using supercritical antisolvent process
    Ha E.-S.
    Kim J.-S.
    Baek I.-H.
    Hwang S.-J.
    Kim M.-S.
    Journal of Pharmaceutical Investigation, 2015, 45 (7) : 641 - 649
  • [50] Improved dissolution and pharmacokinetic behavior of cyclosporine A using high-energy amorphous solid dispersion approach
    Onoue, Satomi
    Sato, Hideyuki
    Ogawa, Kumiko
    Kawabata, Yohei
    Mizumoto, Takahiro
    Yuminoki, Kayo
    Hashimoto, Naofumi
    Yamada, Shizuo
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 399 (1-2) : 94 - 101